Our Mission

Basic and clinical investigators at TIWR aim to combine recent insights and advances in wound healing biology, materials sciences, and bioengineering to create fully-vascularized organ constructs for personalized, regenerative medicine while offering new innovative opportunities for high-throughput drug screening, discovery and development. We expect that this new generation of biomimetic, autologous skin substitutes will extend functionality well beyond that of current products to actively engage the chemically-, mechanically-, or thermally-injured tissues/wound bed, aggressively directing and significantly accelerating a natural healing response to promote wound closure.